Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes.

Cardiopulmonary bypass constitutes an injury that may cause postoperative pathophysiological changes due to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). These complications include coagulopathy, hypotension, capillary leakage, and multiple organ injury. To investigate the role of endotoxin and cytokines in the response to bypass injury, we measured plasma levels of endotoxin and proinflammatory cytokines in 20 pediatric patients before and after bypass. Clinical data, including duration of injury and tests indicative of SIRS/MODS, were collected. Levels of endotoxin, TNF-alpha, IL-6, and IL-8 but not IL-1 beta were significantly increased after bypass. Most of the cytokines have been found to correlate with each other. Endotoxin did not correlate with duration of bypass, cytokines, or SIRS/MODS. In contrast, TNF-alpha and IL-8 correlated with duration of bypass and were associated with SIRS/MODS. Certain clinical complications were associated with specific cytokines. Understanding the role of cytokinemia in SIRS/MODS may lead to better prognostic assessment and therapeutic modalities.

[1]  A Haverich,et al.  Systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.

[2]  R. Muraoka,et al.  Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. , 1996, The Journal of thoracic and cardiovascular surgery.

[3]  R. Bone,et al.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.

[4]  F. Rueda,et al.  Higher cytotoxic activity and increased levels of IL‐1β, IL‐6, and TNF‐α in patients undergoing cardiopulmonary bypass , 1995 .

[5]  T. van der Poll,et al.  Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? , 1995, Shock.

[6]  T. van der Poll,et al.  Model for whole body production of tumour necrosis factor-alpha in experimental endotoxaemia in healthy subjects. , 1994, Clinical science.

[7]  M. Green,et al.  Lung and chest wall mechanical properties before and after cardiac surgery with cardiopulmonary bypass. , 1994, Journal of applied physiology.

[8]  D. Taggart,et al.  Respiratory dysfunction after uncomplicated cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[9]  C. Dinarello,et al.  Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. , 1993, JAMA.

[10]  L. W. Andersen,et al.  Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor‐α concentrations in patients undergoing cardiopulmonary bypass , 1993, Critical care medicine.

[11]  W. van Oeveren,et al.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.

[12]  F. Midgley,et al.  Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery , 1992, Critical care medicine.

[13]  S. Westaby,et al.  Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. , 1992, The Annals of thoracic surgery.

[14]  C. Natanson,et al.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock , 1989, The Journal of experimental medicine.

[15]  J. Gabrilove,et al.  Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.